» Articles » PMID: 35926693

Genetic Mapping of Determinants in Drug Resistance, Virulence, Disease Susceptibility, and Interaction of Host-rodent Malaria Parasites

Overview
Journal Parasitol Int
Publisher Elsevier
Specialty Parasitology
Date 2022 Aug 4
PMID 35926693
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic mapping has been widely employed to search for genes linked to phenotypes/traits of interest. Because of the ease of maintaining rodent malaria parasites in laboratory mice, many genetic crosses of rodent malaria parasites have been performed to map the parasite genes contributing to malaria parasite development, drug resistance, host immune response, and disease pathogenesis. Drs. Richard Carter, David Walliker, and colleagues at the University of Edinburgh, UK, were the pioneers in developing the systems for genetic mapping of malaria parasite traits, including characterization of genetic markers to follow the inheritance and recombination of parasite chromosomes and performing the first genetic cross using rodent malaria parasites. Additionally, many genetic crosses of inbred mice have been performed to link mouse chromosomal loci to the susceptibility to malaria parasite infections. In this chapter, we review and discuss past and recent advances in genetic marker development, performing genetic crosses, and genetic mapping of both parasite and host genes. Genetic mappings using models of rodent malaria parasites and inbred mice have contributed greatly to our understanding of malaria, including parasite development within their hosts, mechanism of drug resistance, and host-parasite interaction.

Citing Articles

Plasmodium yoelii as a model for malaria: insights into pathogenesis, drug resistance, and vaccine development.

Otun O, Achilonu I Mol Biol Rep. 2025; 52(1):208.

PMID: 39907835 PMC: 11799112. DOI: 10.1007/s11033-025-10318-4.


Comparative genomics of Plasmodium yoelii nigeriensis N67 and N67C: genome-wide polymorphisms, differential gene expression, and drug resistance.

Wu J, Oguz C, Teklemichael A, Xu F, Stadler R, Lucky A BMC Genomics. 2024; 25(1):1035.

PMID: 39497038 PMC: 11536827. DOI: 10.1186/s12864-024-10961-4.


Malaria Genomics, Vaccine Development, and Microbiome.

Su X, Stadler R, Xu F, Wu J Pathogens. 2023; 12(8).

PMID: 37624021 PMC: 10459703. DOI: 10.3390/pathogens12081061.

References
1.
Henrici R, van Schalkwyk D, Sutherland C . Modification of and Markedly Reduces Ring-Stage Susceptibility of Plasmodium falciparum to Artemisinin . Antimicrob Agents Chemother. 2019; 64(1). PMC: 7187599. DOI: 10.1128/AAC.01542-19. View

2.
Culleton R, Martinelli A, Hunt P, Carter R . Linkage group selection: rapid gene discovery in malaria parasites. Genome Res. 2005; 15(1):92-7. PMC: 540282. DOI: 10.1101/gr.2866205. View

3.
Min-Oo G, Fortin A, Pitari G, Tam M, Stevenson M, Gros P . Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J Exp Med. 2007; 204(3):511-24. PMC: 2137903. DOI: 10.1084/jem.20061252. View

4.
Ohno T, Nishimura M . Detection of a new cerebral malaria susceptibility locus, using CBA mice. Immunogenetics. 2004; 56(9):675-8. DOI: 10.1007/s00251-004-0739-1. View

5.
Ramaprasad A, Klaus S, Douvropoulou O, Culleton R, Pain A . Plasmodium vinckei genomes provide insights into the pan-genome and evolution of rodent malaria parasites. BMC Biol. 2021; 19(1):69. PMC: 8063448. DOI: 10.1186/s12915-021-00995-5. View